Skip to main content
Clinical Trials/CTRI/2023/07/055613
CTRI/2023/07/055613
Recruiting
Phase 2

Clinical Evaluation on the Effect of KusmandaKshara in Acid Peptic Disease Caused by Helicobacter Pylori. - NI

I0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: K20-K31- Diseases of esophagus, stomach and duodenum
Sponsor
I
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
I

Eligibility Criteria

Inclusion Criteria

  • 1\.Subjects of age group between 20\-60 years satisfying the diagnostic criteria
  • irrespective of religion, caste, occupation and socioeconomic status.
  • 2\.Subjects with clinical signs and symptoms of Acid peptic disease caused by Helicobacter pylori, who have been selected by means of Helicobacter pylori Stool antigen test.
  • 3\.Subjects with classical symptoms of Shoola

Exclusion Criteria

  • 1\.Subjects who are pregnant.
  • 2\.Subjects who are diagnosed with pyloric stenosis, stomach cancer.

Outcomes

Primary Outcomes

Not specified

Similar Trials